AIMS/ BACKGROUND: To assess the presence of bcl-2/JH rearrangements in bone marrow and peripheral blood lymphocytes from patients affected by diseases other than malignant lymphomas. The t(14;18) (q32;q21) translocation, which juxtaposes the bcl-2 oncogene on chromosome 18 and the JH segment of the immunoglobulin heavy chain (IgH) genes on chromosome 14, is found frequently in follicular lymphomas. METHODS: A sensitive semi-nested polymerase chain reaction (PCR) was used to detect t(14;18) translocation in bone marrow aspirates and peripheral blood lymphocytes from 48 patients. In 137 additional individuals peripheral blood lymphocytes only were tested. RESULTS: Cells carrying bcl-2/JH rearrangements were detected in about a quarter of the bone marrow samples and half of the peripheral blood lymphocyte samples. In seven patients, t(14;18) positive cells were found in both the bone marrow and peripheral blood lymphocyte samples. The size of the PCR products and bcl-2/JH DNA sequence analysis showed that the same t(14;18) carrying clone was present in the bone marrow and the corresponding peripheral blood lymphocyte samples in three of these seven patients. Some patients had more than one bcl-2/JH rearrangement. There was no significant correlation between age and the translocation incidence. Cells carrying the t(14;18) translocation were present in peripheral blood lymphocyte samples with a similar incidence--between 47% and 52% in all age groups from 20 to 79 years. Patients older than 80 years had a lower (37%) but not significantly different incidence. CONCLUSIONS: These findings suggest that patients affected by non-lymphoid diseases may have several t(14;18) carrying cells and some of them undergo a clonal expansion. Whether individuals with t(14;18) positive cells are at a higher risk of lymphoid malignancies remains unanswered and further epidemiological studies are required.
AIMS/ BACKGROUND: To assess the presence of bcl-2/JH rearrangements in bone marrow and peripheral blood lymphocytes from patients affected by diseases other than malignant lymphomas. The t(14;18) (q32;q21) translocation, which juxtaposes the bcl-2 oncogene on chromosome 18 and the JH segment of the immunoglobulin heavy chain (IgH) genes on chromosome 14, is found frequently in follicular lymphomas. METHODS: A sensitive semi-nested polymerase chain reaction (PCR) was used to detect t(14;18) translocation in bone marrow aspirates and peripheral blood lymphocytes from 48 patients. In 137 additional individuals peripheral blood lymphocytes only were tested. RESULTS: Cells carrying bcl-2/JH rearrangements were detected in about a quarter of the bone marrow samples and half of the peripheral blood lymphocyte samples. In seven patients, t(14;18) positive cells were found in both the bone marrow and peripheral blood lymphocyte samples. The size of the PCR products and bcl-2/JH DNA sequence analysis showed that the same t(14;18) carrying clone was present in the bone marrow and the corresponding peripheral blood lymphocyte samples in three of these seven patients. Some patients had more than one bcl-2/JH rearrangement. There was no significant correlation between age and the translocation incidence. Cells carrying the t(14;18) translocation were present in peripheral blood lymphocyte samples with a similar incidence--between 47% and 52% in all age groups from 20 to 79 years. Patients older than 80 years had a lower (37%) but not significantly different incidence. CONCLUSIONS: These findings suggest that patients affected by non-lymphoid diseases may have several t(14;18) carrying cells and some of them undergo a clonal expansion. Whether individuals with t(14;18) positive cells are at a higher risk of lymphoid malignancies remains unanswered and further epidemiological studies are required.
Authors: M Kneba; S Eick; H Herbst; S Willigeroth; C Pott; I Bolz; M Bergholz; C Neumann; H Stein; G Krieger Journal: Cancer Res Date: 1991-06-15 Impact factor: 12.701
Authors: Sharon L Barrans; Paul A S Evans; Sheila J M O'Connor; Roger G Owen; Gareth J Morgan; Andrew S Jack Journal: J Mol Diagn Date: 2003-08 Impact factor: 5.568
Authors: Cindy M Chang; Jane C Schroeder; Andrew F Olshan; Cherie H Dunphy; Wen-Yi Huang; Ralph S Baric; Kathleen Conway; James R Cerhan; Charles F Lynch; Nathaniel Rothman; Kenneth P Cantor; Aaron Blair Journal: Cancer Causes Control Date: 2010-03-16 Impact factor: 2.506
Authors: Carsten Hirt; Kerstin Weitmann; Frank Schüler; Thomas Kiefer; Charles S Rabkin; Wolfgang Hoffmann; Gottfried Dölken Journal: Leuk Lymphoma Date: 2013-05-07
Authors: Frank Schüler; Lars Dölken; Carsten Hirt; Thomas Kiefer; Tobias Berg; Gerhard Fusch; K Weitmann; W Hoffmann; Christoph Fusch; Siegfried Janz; Charles S Rabkin; Gottfried Dölken Journal: Int J Cancer Date: 2009-02-15 Impact factor: 7.396
Authors: María Sol Brassesco; Ana Paula Montaldi; Diana Ester Gras; Rosane Gomes de Paula Queiroz; Nilce Maria Martinez-Rossi; Luiz Gonzaga Tone; Elza Tiemi Sakamoto-Hojo Journal: Genet Mol Biol Date: 2009-06-01 Impact factor: 1.771
Authors: Joe Shuga; Yong Zeng; Richard Novak; Qing Lan; Xiaojiang Tang; Nathaniel Rothman; Roel Vermeulen; Laiyu Li; Alan Hubbard; Luoping Zhang; Richard A Mathies; Martyn T Smith Journal: Nucleic Acids Res Date: 2013-07-19 Impact factor: 16.971